References - Therapeutic Strategies in Cancer Biology and Pathology - page 229

Lopez-Girona, A., Furnari, B., Mondesert, O., Russell, P., 1999. Nuclear localization of Cdc25
is regulated by DNA damage and a 14-3-3 protein. Nature 397, 172-175.
Lopez-Lago, M.A., Thodima, V.J., Guttapalli, A., Chan, T., Heguy, A., Molina, A.M., et al.,
2010. Genomic deregulation during metastasis of renal cell carcinoma implements a
myofibroblast-like program of gene expression. Cancer Res. 70, 9682-9692.
Lorenz, K., Lohse, M.J., Quitterer, U., 2003. Protein kinase C switches the Raf kinase inhibi-
tor from Raf-1 to GRK-2. Nature 426, 574-579.
LoRusso, P.M., Rudin, C.M., Reddy, J.C., Tibes, R., Weiss, G.J., Borad, M.J., et al., 2011.
Phase I trial of hedgehog pathway inhibitor GDC-0449 in patients with refractory,
locally-advanced or metastatic solid tumors. Clin. Cancer Res. 17, 2502-2511.
Lou, Y., Cui, Z., Wang, F., Yang, X., Qian, J., 2011. miR-21 down-regulation promotes apopto-
sis and inhibits invasion and migration abilities of OVCAR3 cells. Clin. Invest. Med. 34,
E281-E289.
Lowery, A.J., Miller, N., Dwyer, R.M., Kerin, M.J., 2010. Dysregulated miR-183 inhibits
migration in breast cancer cells. BMC Cancer 10, 502.
Lu, C., Han, H.D., Mangala, L.S., Ali-Fehmi, R., Newton, C.S., Ozbun, L., et al., 2010.
Regulation of tumor angiogenesis by EZH2. Cancer Cell 18, 185-197.
Lu, D., Choi, M.Y., Yu, J., Castro, J.E., Kipps, T.J., Carson, D.A., 2011a. Salinomycin inhibits
Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells.
Proc. Natl. Acad. Sci. U.S.A. 108, 13253-13257.
Lu, F., Dai, D.L., Martinka, M., Ho, V., Li, G., 2006. Nuclear ING2 expression is reduced in
human cutaneous melanomas. Br. J. Cancer 95, 80-86.
Lu, M.L., Chen, F., Wang, Q.W., Wang, K.S., Pan, Q.H., Zhang, X., 2012. Downregulation of
inhibitor of growth 3 is correlated with tumorigenesis and progression of hepatocellular
carcinoma. Oncol. Lett. 4, 47-52.
Lu, W., Lin, C., Roberts, M.J., Waud, W.R., Piazza, G.A., Li, Y., 2011b. Niclosamide sup-
presses cancer cell growth by inducing Wnt co-receptor LRP6 degradation and inhibiting
the Wnt/beta-catenin pathway. PloS ONE 6, e29290.
Luetzner, N., Arce, J.De.-C., Roesl, F., 2012. Gene expression of the tumour suppressor LKB1
is mediated by Sp1, NF-Y and FOXO transcription factors. PloS ONE 7, e32590.
Luo, J., Feng, J., Lu, J., Wang, Y., Tang, X., Xie, F., et al., 2010. Aberrant methylation pro-
file of 14-3-3 sigma and its reduced transcription/expression levels in Chinese sporadic
female breast carcinogenesis. Med. Oncol. 27, 791-797.
Lyden, D., Young, A.Z., Zagzag, D., Yan, W., Gerald, W., O'Reilly, R. et al. (1999). Id1 and
Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts.
Nature 401, 670-677.
Ma, W., Lee, S.E., Guo, J., Qu, W., Hudson, B.L., Schmidt, A.M., et al., 2007. RAGE Ligand
Upregulation of VEGF Secretion in ARPE-19 Cells. Invest. Ophthalmol. Vis. Sci. 48,
1355-1361.
Maass, N., Hojo, T., Ueding, M., Luttges, J., Kloppel, G., Jonat, W., et al., 2001. Expression
of the tumor suppressor gene maspin in human pancreatic cancers. Clin. Cancer Res. 7,
812-817.
Maass, N., Nagasaki, K., Ziebart, M., Mundhenke, C., Jonat, W., 2002. Expression and
regulation of tumor suppressor gene maspin in breast cancer. Clin. Breast Cancer 3,
281-287.
Machado, R., Rafael, F., Trevisan, P., Koshiyama, D.B., Pilla, C.B., Gazzola, Z., et al., 2010.
22q11.2 deletion syndrome and complex congenital heart defects. Rev. Assoc. Med.
Brasil 57, 62-65.